-
公开(公告)号:US20100152166A1
公开(公告)日:2010-06-17
申请号:US12600879
申请日:2008-07-11
申请人: Michael James Genin , Francisco Javier Agejas-Chicharro , Ana Belen Bueno Melendo , Peter Rudolph Manninen , Alan M. Warshawsky
发明人: Michael James Genin , Francisco Javier Agejas-Chicharro , Ana Belen Bueno Melendo , Peter Rudolph Manninen , Alan M. Warshawsky
IPC分类号: A61K31/55 , C07D413/12 , A61K31/454 , C07D403/14 , C07D409/14 , A61P3/00 , A61K31/444 , C07D261/06 , A61K31/42
CPC分类号: C07D261/08 , C07D413/12
摘要: Compounds of formula (I): formula (I) wherein variables are as defined herein and their pharmaceutical compositions and methods of use are disclosed as useful for treating dyslipidemia and diseases related to dyslipidemia.
摘要翻译: 公开了式(I)化合物:其中变量如本文所定义的式(I)及其药物组合物和使用方法用于治疗血脂异常和与血脂异常有关的疾病。
-
公开(公告)号:US07618978B2
公开(公告)日:2009-11-17
申请号:US10599125
申请日:2005-04-08
IPC分类号: A61K31/445
CPC分类号: C07D413/04 , C07D207/08 , C07D207/12 , C07D211/26 , C07D211/42 , C07D217/18 , C07D241/04 , C07D241/08 , C07D401/12 , C07D403/12 , C07D409/12 , C07D413/14 , C07D417/12 , C07D471/08
摘要: The present invention provides BACE inhibitors of Formula (I): methods for their use, and intermediates and methods for their preparation.
摘要翻译: 本发明提供式(I)的BACE抑制剂:其用途及其制备方法。
-
公开(公告)号:US07335660B2
公开(公告)日:2008-02-26
申请号:US10496535
申请日:2002-12-06
申请人: Javier Agejas-Chicharro , Graham Henry Timms , Andrew Caerwyn Williams , Nicholas Paul Camp , Jeremy Gilmore , Ana Belen Bueno Melendo , Carlos Lamas-Peteira
发明人: Javier Agejas-Chicharro , Graham Henry Timms , Andrew Caerwyn Williams , Nicholas Paul Camp , Jeremy Gilmore , Ana Belen Bueno Melendo , Carlos Lamas-Peteira
IPC分类号: A61K31/496 , C07D311/76 , C07D405/06 , C07D409/12 , C07D413/12 , C07D413/06 , C07D413/14 , C07D413/04 , C07D407/06 , C07D409/14 , C07D405/04 , C07D417/12 , C07D405/12
CPC分类号: C07D405/06 , C07D307/87 , C07D311/76 , C07D405/14 , C07D409/12 , C07D409/14 , C07D413/04 , C07D413/14 , C07D417/04
摘要: This invention relates to compounds of formula (I) where R1 to R12, —W—V—, —X—Y—, p and n have the values defined in claim 1, their preparation and use as pharmaceuticals for the treatment of central nervous system disorders, such as depression, bipolar disorder, and anxiety.
摘要翻译: 本发明涉及其中R 1至R 12,-WV-,-XY-,p和n具有权利要求1中定义的值的式(I)化合物, 其制备和用作药物用于治疗中枢神经系统疾病,例如抑郁症,双相性精神障碍和焦虑症。
-
-